Arabella Young

6.7k total citations · 3 hit papers
47 papers, 4.4k citations indexed

About

Arabella Young is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Arabella Young has authored 47 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 15 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Arabella Young's work include Cancer Immunotherapy and Biomarkers (31 papers), Immune Cell Function and Interaction (11 papers) and CAR-T cell therapy research (9 papers). Arabella Young is often cited by papers focused on Cancer Immunotherapy and Biomarkers (31 papers), Immune Cell Function and Interaction (11 papers) and CAR-T cell therapy research (9 papers). Arabella Young collaborates with scholars based in United States, Australia and Japan. Arabella Young's co-authors include Mark J. Smyth, Michele W.L. Teng, Dipti Vijayan, Shin Foong Ngiow, Jeffrey A. Bluestone, Zoe Quandt, Deepak Mittal, John Stagg, Stephen J. Blake and Kazuyoshi Takeda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Arabella Young

43 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting immunosuppressive adenosine in cancer

2017 608 citations Dipti Vijayan, Arabella Young et al. Nature reviews. Cancer profile →
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

2016 569 citations Jing Liu, Stephen J. Blake et al. Cancer Discovery profile →
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

2018 412 citations Zoe Quandt, Ana Luisa Perdigoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arabella Young United States	23	2.6k	2.0k	1.1k	979	535	47	4.4k
Bertrand Allard Canada	24	1.8k 0.7×	1.7k 0.8×	1.0k 0.9×	1.8k 1.9×	229 0.4×	43	3.7k
A. Kate Sasser United States	24	2.6k 1.0×	1.0k 0.5×	1.8k 1.6×	334 0.3×	187 0.3×	54	4.5k
Meriem Hasmim France	28	2.2k 0.8×	2.1k 1.1×	1.5k 1.4×	133 0.1×	536 1.0×	42	4.6k
Laura Strauss United States	29	2.0k 0.8×	3.2k 1.6×	1.1k 1.0×	98 0.1×	303 0.6×	46	4.5k
Ashley V. Menk United States	24	1.9k 0.7×	2.8k 1.4×	1.5k 1.4×	90 0.1×	324 0.6×	34	4.6k
Jan Dürig Germany	39	1.1k 0.4×	1.7k 0.9×	1.3k 1.2×	219 0.2×	292 0.5×	143	4.5k
Rahul Roychoudhuri United Kingdom	25	1.6k 0.6×	2.3k 1.1×	1.4k 1.3×	63 0.1×	288 0.5×	46	4.2k
Michael K.K. Wong United States	15	567 0.2×	553 0.3×	931 0.8×	524 0.5×	173 0.3×	25	2.1k
Erik Wennerberg United States	23	1.7k 0.6×	1.5k 0.7×	446 0.4×	100 0.1×	406 0.8×	40	2.5k
Eyal C. Attar United States	32	949 0.4×	843 0.4×	2.1k 1.9×	98 0.1×	282 0.5×	117	4.5k

Countries citing papers authored by Arabella Young

Since Specialization

Citations

This map shows the geographic impact of Arabella Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arabella Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arabella Young more than expected).

Fields of papers citing papers by Arabella Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arabella Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arabella Young. The network helps show where Arabella Young may publish in the future.

Co-authorship network of co-authors of Arabella Young

This figure shows the co-authorship network connecting the top 25 collaborators of Arabella Young. A scholar is included among the top collaborators of Arabella Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arabella Young. Arabella Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jiahui, Emilio Cortes-Sanchez, Matthew W. VanBrocklin, et al.. (2025). Polymer-based chemo-immunotherapy: Combining immunogenic cell death induction and PD-L1 blockade enhances antitumor immunity in melanoma. Journal of Controlled Release. 387. 114193–114193.

McPherson, Jordan P., et al.. (2025). The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors. Nature reviews. Cancer. 26(2). 137–158.

Barlow, Graham L., Christian M. Schürch, Salil S. Bhate, et al.. (2025). The extra-islet pancreas supports autoimmunity in human type 1 diabetes. eLife. 13. 2 indexed citations

Fadlullah, Muhammad Zaki Hidayatullah, et al.. (2024). Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials. The Oncologist. 29(5). 415–421. 1 indexed citations

Young, Arabella, et al.. (2023). Stocking the toolbox—Using preclinical models to understand the development and treatment of immune checkpoint inhibitor‐induced immune‐related adverse events. Immunological Reviews. 318(1). 110–137. 5 indexed citations

Quandt, Zoe, Stephanie Kim, Javier Villanueva‐Meyer, et al.. (2023). Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis. Journal of the Endocrine Society. 7(4). bvad012–bvad012. 19 indexed citations

Quandt, Zoe, Marshall R Thompson, Ashis Saha, et al.. (2023). 1238 Risk evaluation of immune checkpoint inhibitor diabetes through islet autoantibodies & HLA types in a large, real-world cohort. SHILAP Revista de lepidopterología. A1366–A1366. 1 indexed citations

Lee, James, Sadaf Mehdizadeh, Jennifer Smith, et al.. (2020). Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Science Immunology. 5(52). 198 indexed citations

Ngiow, Shin Foong & Arabella Young. (2020). Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies. Frontiers in Immunology. 11. 1633–1633. 25 indexed citations

10.

Young, Arabella, Shin Foong Ngiow, Ann‐Marie Patch, et al.. (2017). A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. Cancer Research. 78(4). 1003–1016. 296 indexed citations

11.

Young, Arabella, Shin Foong Ngiow, Jason Madore, et al.. (2017). Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. Cancer Research. 77(17). 4684–4696. 76 indexed citations

12.

Casciello, Francesco, Fares Al‐Ejeh, Greg Kelly, et al.. (2017). G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis. Proceedings of the National Academy of Sciences. 114(27). 7077–7082. 104 indexed citations

13.

Vijayan, Dipti, Arabella Young, Michele W.L. Teng, & Mark J. Smyth. (2017). Targeting immunosuppressive adenosine in cancer. Nature reviews. Cancer. 17(12). 709–724. 608 indexed citations breakdown →

14.

Ngiow, Shin Foong, Arabella Young, Stephen J. Blake, et al.. (2016). Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell–Rich Tumor. Cancer Research. 76(21). 6266–6277. 72 indexed citations

15.

Mittal, Deepak, Debottam Sinha, Deborah S. Barkauskas, et al.. (2016). Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis. Cancer Research. 76(15). 4372–4382. 142 indexed citations

16.

Liu, Jing, Stephen J. Blake, Michelle C.R. Yong, et al.. (2016). Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. Cancer Discovery. 6(12). 1382–1399. 569 indexed citations breakdown →

17.

Ngiow, Shin Foong, Arabella Young, Nicolas Jacquelot, et al.. (2015). A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Research. 75(18). 3800–3811. 184 indexed citations

18.

Souza-Fonseca-Guimarães, Fernando, Arabella Young, Deepak Mittal, et al.. (2015). NK cells require IL-28R for optimal in vivo activity. Proceedings of the National Academy of Sciences. 112(18). E2376–84. 76 indexed citations

19.

Taberlay, Phillippa C., Arabella Young, Alison C. West, et al.. (2015). The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1. Journal of Cellular Biochemistry. 117(1). 49–58. 9 indexed citations

20.

Young, Arabella, Adele F. Holloway, Nicholas B. Blackburn, et al.. (2014). RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. BMC Cancer. 14(1). 808–808. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact